Onconova Therapeutics, Inc. Business Finance Contracts & Agreements
63 Contracts & Agreements
- Equity Distribution Agreements (1 contract)
- Exchange Agreements (1)
- Purchase Agreements (12)
- Registration Rights Agreements (1)
- Stock Agreements (5)
- Underwriting Agreements (10)
- Waiver Agreements (1)
- Warrant Agreements (32)
- Form of Non-Qualified Stock Option Agreement (Filed With SEC on November 15, 2021)
- Form of Restricted Stock Unit Agreement (Filed With SEC on November 15, 2021)
- Underwriting Agreement, dated September 23, 2021, by and between Onconova Therapeutics, Inc. and Guggenheim Securities, LLC (Filed With SEC on September 24, 2021)
- Equity Distribution Agreement, dated as of August 20, 2021, between Onconova Therapeutics, Inc. and Piper Sandler & Co (Filed With SEC on August 20, 2021)
- Underwriting Agreement, dated February 10, 2021, by and between Onconova Therapeutics, Inc. and Guggenheim Securities, LLC (Filed With SEC on February 12, 2021)
- Form of Purchase Agreement, dated as of January 7, 2021, by and among Onconova Therapeutics, Inc. and the investors party thereto (Filed With SEC on January 8, 2021)
- Form of Stock Appreciation Right Award Agreement (for Non-Employee Directors) (Filed With SEC on November 16, 2020)
- Form of Stock Appreciation Right Award Agreement (Filed With SEC on July 10, 2020)
- Form of Securities Purchase Agreement, dated as of December 31, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on January 3, 2020)
- Form of Placement Agent Warrant (Filed With SEC on January 3, 2020)
- Form of Securities Purchase Agreement, dated as of December 17, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on December 19, 2019)
- Form of Placement Agent Warrant (Filed With SEC on December 19, 2019)
- Form of Investor Warrant (Filed With SEC on December 19, 2019)
- Form of Securities Purchase Agreement, dated as of December 6, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on December 10, 2019)
- Form of Placement Agent Warrant (Filed With SEC on December 10, 2019)
- Form of Investor Warrant (Filed With SEC on December 10, 2019)
- Form of Securities Purchase Agreement, dated as of November 21, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on November 26, 2019)
- Form of Placement Agent Warrant (Filed With SEC on November 26, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on November 26, 2019)
- Form of Common Warrant (Filed With SEC on November 26, 2019)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 14, 2019)
- Form of Placement Agent Warrant (Filed With SEC on November 14, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on November 14, 2019)
- Form of Warrant (Filed With SEC on November 14, 2019)
- Form of Underwriter Warrant (Filed With SEC on November 12, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on November 12, 2019)
- Form of Warrant (Filed With SEC on November 12, 2019)
- Form of Underwriting Agreement (Filed With SEC on November 12, 2019)
- Form of Amendment to Warrant, dated as of September 23, 2019 (Filed With SEC on November 12, 2019)
- Form of Securities Purchase Agreement, dated as of September 23, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on September 25, 2019)
- Form of Placement Agent Warrant (Filed With SEC on September 25, 2019)
- Securities Purchase Agreement, dated as of May 10, 2019, by and between Onconova Therapeutics, Inc. and Abundant New Investments Ltd (Filed With SEC on August 14, 2019)
- Securities Purchase Agreement, dated as of May 10, 2019, by and between Onconova Therapeutics, Inc. and HanX Biopharmaceuticals, Inc (Filed With SEC on August 14, 2019)
- First Amendment to Underwriter Series A Convertible Preferred Stock Purchase Warrant, dated as of September 24, 2018 (Filed With SEC on November 14, 2018)
- Securities Purchase Agreement, dated as of March 2, 2018, by and between Onconova Therapeutics, Inc. and Pint Pharma GmbH (Filed With SEC on May 15, 2018)
- Form of Lock-Up Waiver Agreement (Filed With SEC on April 30, 2018)
- Form of Pre-Funded Warrant (Filed With SEC on April 30, 2018)
- Form of Preferred Stock Warrant (Filed With SEC on April 30, 2018)
- Underwriting Agreement, dated as of April 27, 2018 (Filed With SEC on April 30, 2018)
- Form of Underwriting Agreement (Filed With SEC on April 26, 2018)
